For example, the bone marrow-derived MSCs (BMSCs) can induce breast cancer cells into dormancy via the paracrine route to activate the JAK/STAT3 signaling pathway (Leyh et al., 2015), which partly illuminates the reasons why the metastatic latency period of breast cancer can prolong to 25 years after primary tumor resection. Here, STAT3 is linked to breast carcinoma.